October 27, 2018 By Kendall Nelson<\/p>\n\n\n\n
Ten\n years ago, my producing partners and I flew to Kansas to film with Gaby\n Swank, a beautiful fifteen-year-old girl who had suffered severe \nadverse reactions to the human papillomavirus (HPV) vaccine, Gardasil. \nOur intention was to interview Gaby so she could tell her vaccine-injury\n story in our documentary, The Greater Good<\/em>.<\/p>\n\n\n\n When we arrived at her house, her mother led us to a room where we \nfound Gaby lying in bed with the lights off, chronically fatigued, \nmuscles aching\u2014wearing an \u201cI Don\u2019t Want to Be One Less\u201d tee-shirt. The \nwriting on Gaby\u2019s shirt referred to an ad campaign created by the \npharmaceutical company Merck. The ads targeted teenage girls, suggesting\n they could be \u201cone less\u201d victim of cervical cancer if they got the HPV \nvaccine.1<\/sup> The television commercial that prompted Gaby to get\n vaccinated opened with a girl at a skateboard park wearing her baseball\n cap backwards, saying to the camera, \u201cI could be one less.\u201d It then \nwent on to feature other enviable girls playing soccer, dancing and \nskipping rope to a \u201cbe one less\u201d chant. The imagery was so alluring that\n neither Gaby nor her mother noticed the warnings embedded within the ad\n mentioning a long list of side effects, nor did they note the statement\n that Gardasil does not protect against all types of cervical cancer.<\/p>\n\n\n\n During the first year that Gardasil was on the market, Merck spent \none hundred million dollars advertising their HPV vaccine to girls like \nGaby. Unfortunately, what Gaby and her mother saw as a health benefit \nrapidly became a health nightmare after Gaby followed the Centers for \nDisease Control and Prevention (CDC) recommendation to get three doses \nof Gardasil. Once a varsity cheerleader and straight-A student, Gaby was\n no longer able to attend school, hang out with friends or walk long \ndistances. She suffered two strokes, partial paralysis on the right side\n of her face and partial vision loss. She also experienced multiple \ndaily seizures. Gaby would later be diagnosed with postural orthostatic \ntachycardia syndrome (POTS), a disease that causes dysfunction of the \nautonomic nervous system; central nervous system (CNS) lupus, a disease \nin which the immune system attacks the body\u2019s own cells and tissues; \ncerebral vasculitis, a disease that causes inflammation of blood vessels\n that can restrict blood flow, resulting in organ and tissue damage; and\n fibromyalgia disorder, characterized by widespread musculoskeletal pain\n accompanied by fatigue, sleep, memory and mood issues.<\/p>\n\n\n\n ADVERSE REACTIONS UNDERREPORTED<\/strong> Part of the problem is that many doctors don\u2019t even know that there \nis a government system for reporting adverse events, called the Vaccine \nAdverse Event Reporting System (VAERS).5<\/sup> For those who do, the system is complicated and time-consuming to use.6<\/sup>\n Another barrier to reporting adverse reactions is what doctors are \ntaught in medical school\u2014that vaccines are so safe, they may never \nencounter a vaccine reaction during their entire career. Therefore, \ndoctors often do not realize that medical conditions arising after \nvaccination could be vaccine-related injuries.<\/p>\n\n\n\n A 2016 study out of Canada highlighted the under-reporting of vaccine\n injuries. The study looked at over one hundred ninety-five thousand \ngirls who had received HPV vaccines. Within forty-two days of HPV \nvaccination, the girls experienced over twenty thousand emergency room \nvisits (n=19,351) or hospitalizations (n=958). However, only one hundred\n and ninety-eight adverse events were reported.7<\/sup><\/p>\n\n\n\n HIDING AND DENYING THE DAMAGE<\/strong> Some efforts to minimize the evidence of serious adverse reactions to\n HPV vaccines may go so far as to constitute criminal activity. In 2016,\n Dr. Sin Hang Lee, a scientist and doctor, wrote an open letter of \ncomplaint to Dr. Margaret Chan, at the time the director-general of the \nWorld Health Organization (WHO). Dr. Lee\u2019s letter alleged scientific \nmisconduct and cover-up of HPV vaccine dangers by global health \nofficials.10<\/sup> The source of information for Dr. Lee\u2019s letter \nwas a trail of emails and other communications between global health \nofficials obtained via an Official Information Act request in New \nZealand. The communications provided evidence that the same officials \nwho were busy reassuring the public that HPV vaccines were safe knew \nthat Gardasil and Cervarix were more likely than other vaccines to cause\n a potentially dangerous inflammatory response.<\/p>\n\n\n\n Specifically, WHO officials knew that the vaccines trigger the \nrelease of cytokines or proteins called tumor necrosis factors (TNFs), \nwhich can cause cell death.11<\/sup> The release of TNFs can also \nresult in a wide range of reactions such as tumor regression, septic \nshock (a serious whole-body inflammatory response that can result in \ndangerously low blood pressure and death) and cachexia (a wasting \nsyndrome where the person loses weight, becomes fatigued and experiences\n muscle atrophy).12<\/sup><\/p>\n\n\n\n THE RUSH TO MARKET<\/strong> In addition to the potentially fraudulent fast-tracking of Gardasil, \nthe vaccine was only studied in twelve hundred girls under the age of \nsixteen before its recommendation for universal use in all eleven- to \ntwelve-year-old girls. No studies looked at Gardasil\u2019s use in children \nwith preexisting health problems or its use in combination with the \nother vaccines routinely given to American adolescents.16<\/sup> \nSimilarly, Cervarix, which was licensed in the U.S. in 2009, was studied\n for less than six years in fewer than twelve hundred healthy girls \nunder the age of fifteen.<\/p>\n\n\n\n Typically, trials of new drugs compare one group that is given the \ndrug against a \u201ccontrol\u201d group that is given an inert (inactive) \nplacebo, most often a saline solution. However, the clinical trials for \nGardasil and Cervarix did not use a legitimate placebo in each of their \ncontrol groups.17<\/sup> Instead of receiving a saline solution, \nparticipants in several of the Gardasil control groups received aluminum\n in the form of a neurotoxic adjuvant present in all HPV vaccines. In \nthe case of Cervarix, control group participants were given hepatitis A \nvaccine or other childhood vaccines\u2014capable of causing adverse \nreactions\u2014in lieu of a true placebo. Did this result in fraudulent \nconclusions? One might ask, how is it possible to detect adverse \nreactions properly without a legitimate control group?16<\/sup><\/p>\n\n\n\n CORPORATE TRACK RECORD<\/strong> When we interviewed Dr. Diane Harper, one of the world\u2019s leading HPV \nexperts and principal investigator for Merck\u2019s Gardasil and GSK\u2019s \nCervarix clinical trials, she raised concerns about both vaccines and \ndescribed Merck\u2019s advertising campaign as \u201cegregious and aggressive.\u201d \nDr. Russell Blaylock, a retired neurosurgeon and health freedom \nadvocate, has gone so far as to say that Merck\u2019s widely aired One Less<\/em> campaign was a \u201ccomplete fraud.\u201d Blaylock proclaimed, \u201cIt has never been shown that (Gardasil) prevents cervical cancer.\u201d22<\/sup>\n According to Harper, \u201cThe concept that our daughters are cancer deaths \nwaiting to happen is just not accurate,\u201d yet Merck has not been shy \nabout insinuating just that.<\/p>\n\n\n\n Another fact important to understand, again explained by Harper, is \nthat there are no data showing that HPV vaccines remain effective beyond\n five years, while a full fifteen years of immunity coverage are \nnecessary to prevent cervical cancer. In Harper\u2019s view, the moment Merck\n gained FDA approval for Gardasil, the company stopped studying the \nvaccine, performing no long-term safety monitoring.<\/p>\n\n\n\n WHICH IS RISKIER?<\/strong> A study by researchers at the University of Texas looked at HPV \nvaccination data from 2007\u20132012. The results showed that young women \ntwenty to twenty-six years of age who received the four-strain Gardasil \nvaccine were actually more likely than non-HPV-vaccinated women to be \ninfected with high-risk nonvaccine strains of HPV ten years later.26<\/sup>\n The implications of these results are sobering, suggesting that while \nthe vaccine may have reduced infection with the four targeted HPV \nstrains, \u201cother, possibly more pathogenic, HPV viruses moved in to fill \nthe void\u201d; in other words, the vaccine \u201cexposed the girls who took it to\n greater risk for HPV infection than those that did not take the \nvaccine.\u201d27<\/sup><\/p>\n\n\n\n MISLEADING MARKETING<\/strong> Merck followed its initial One Less<\/em> campaign with its I Chose<\/em>\n advertising campaign in 2008, which featured a variety of young women \nexplaining why they decided to get vaccinated, ending with one woman \nexplaining that her dreams don\u2019t include cervical cancer. Then, a decade\n after Gardasil\u2019s introduction, Merck shifted from One Less and I Chose \nto attempts to shame parents into getting their children vaccinated, \nplaying on parents\u2019 basic instinct to protect their children. (One could\n easily label the 2016 campaign as the Who Knew? campaign, with both \nboys and girls asking their parents in the television commercials, \u201cDid \nyou know\u2014Mom, Dad?\u201d)<\/p>\n\n\n\n Up until that point, the vaccine had not been heavily promoted to \nboys and young men, despite FDA approval for males in 2009. All that \nchanged in 2016 when Merck began targeting all eleven- to \ntwelve-year-olds, female or male. Oddly, not until 2018 did a Merck \nadvertisement even mention how one contracts HPV (through intimate \nsexual contact). The newest Versed ad campaign aims to educate youth by \ntelling them to \u201cget smart about HPV\u201d and get \u201cvocal.\u201d<\/p>\n\n\n\n Despite the huge amounts of money spent on HPV vaccine advertising, \nconsumers in the U.S. apparently are not taking the bait. HPV vaccines \nhave had a persistently low adoption rate. According to the CDC, as of \n2016, fewer than half of seventeen-year-olds (49.5 percent of girls and \n37.5 percent of boys) were up to date with the recommended HPV vaccine \nseries,29<\/sup> falling far short of the health agency\u2019s 2020 goal for 80 percent of both girls and boys to be HPV-vaccinated.30<\/sup><\/p>\n\n\n\n It\u2019s not just U.S. citizens who are getting wise to HPV vaccination dangers. Several countries\u2014including Japan,31<\/sup> France32<\/sup> and India33<\/sup>\u2014have\n stopped recommending HPV vaccines and\/or have filed lawsuits on behalf \nof HPV-vaccine-injured families. In Japan, Gardasil has become such a \nscandal that the country\u2019s uptake rate is currently under 1 percent.34<\/sup>\n In many European Union (EU) countries, HPV vaccine coverage rates \nremain \u201clower than expected,\u201d and some EU countries make individuals who\n want the pricy vaccine pay for it themselves.35<\/sup> In Ireland, a group of parents with Gardasil-injured children is formally known as \u201cRegret.\u201d36<\/sup><\/p>\n\n\n\n FERTILITY AT RISK<\/strong> Other research has implicated aluminum in fertility problems. Dr. \nChristopher Exley, an aluminum expert at Keele University in England, \nexamined sixty-two semen samples and found \u201cunequivocal evidence\u201d of \nhigh concentrations of aluminum, especially in the semen of men with low\n sperm counts.41<\/sup> Another toxic ingredient found in Merck\u2019s \nGardasil vaccines is polysorbate 80, which has been associated with a \nmyriad of health problems and has proven to cause ovarian toxicity in \nrats.42<\/sup> Polysorbate 80 was used along with aluminum in some of Merck\u2019s bogus \u201cplacebo\u201d control groups in prelicensure studies.38<\/sup><\/p>\n\n\n\n EXTENDING THE VACCINE\u2019S REACH<\/strong> In fact, mandating any vaccine is unethical\u2014whether for students, \nparent volunteers, health care workers or any other person\u2014especially \nbecause vaccine manufacturers are virtually exempt from liability in the\n U.S. The National Childhood Vaccine Injury Act (NCVIA) of 1986 made it \nalmost impossible to sue pharmaceutical companies or those who \nadminister vaccines if a person becomes vaccine-injured. Instead, that \nperson must appeal to the government-run National Vaccine Injury \nCompensation Program (NVICP), which has a terrible reputation for \nfinancially compensating those injured or killed by vaccines. That said,\n the program has paid almost six million dollars to forty-nine Americans\n after the U.S. Court of Federal Claims found that Gardasil had injured \nthe individuals.44<\/sup><\/p>\n\n\n\n As of June 2018, we have something new to worry about: Merck has \nreceived an FDA \u201cpriority review\u201d to expand Gardasil to women and men \naged twenty-seven to forty-five years.45<\/sup> Merck is pushing for\n expansion to this age group despite the fact that most adults have \nalready been exposed to HPV by those ages. Merck itself writes, \n\u201cGardasil-9 has not been demonstrated to provide protection against \ndiseases from vaccine HPV types to which a person has previously been \nexposed through sexual activity.\u201d46<\/sup><\/p>\n\n\n\n THE WORST VACCINE<\/strong> For many, HPV vaccines are reminiscent of the thalidomide scandal of \nthe 1960s, when doctors prescribed the drug to pregnant women to \nalleviate morning sickness. Unfortunately, thalidomide caused phocomelia\n (malformation of the limbs), affecting thousands of children worldwide \nand often resulting in death.<\/p>\n\n\n\n Dr. Bernard Dalbergue (former physician at Merck) predicted in 2014 \nthat the Gardasil vaccine would become \u201cthe greatest medical scandal of \nall time.\u201d47<\/sup> Dr. Russell Blaylock likewise has concluded that\n the harm from HPV vaccines far exceeds any claimed benefits. According \nto Blaylock, \u201cThe general public is woefully unaware of the fact that \nvitamin B12<\/sub>, folic acid, vitamin C, curcumin (turmeric), \nquercetin and many other natural nutrients and vitamins naturally \nprevent HPV and cervical cancer.\u201d22<\/sup> Attention to health and \nnutrition can address many of the factors that increase the risk of \ndeveloping HPV-related cancers, which include smoking; long-term oral \ncontraceptive use; a weakened immune system; co-infection with chlamydia\n or HIV; poor nutrition; deficiencies of vitamins C and B, carotenes and\n folate; heavy drinking; and chronic inflammation.<\/p>\n\n\n\n When women face only a 0.6 percent risk of cervical cancer and men \nface a 0.2 percent risk of rare anal and penile cancers, it seems \nirrational to continue using a vaccine with so many complications, let \nalone mandate the vaccine or expand the age groups covered by HPV \nvaccine recommendations. These vaccines have been plagued by controversy\n since their inception, causing more injury than any other vaccine in \nhistory. Despite an undeniable litany of adverse effects that includes \ndeath, the vaccines continue to be administered to millions of people \nwithout their fully informed consent. In addition, the HPV vaccines may \nwell be worthless for their stated purpose\u2014their heavy marketing as \n\u201ccancer prevention\u201d proceeds despite the fact that no long-term studies \nhave ever been done to prove their efficacy. Blaylock says\u2014and I \nagree\u2014that \u201cthe entire vaccine program is based upon nonsense, fear and \nconcocted fairy tales.\u201d No amount of Merck\u2019s clever advertising will \nconvince me otherwise. Only unbiased, credible science could change my \nmind, and so far, that kind of science has not been done.<\/p>\n\n\n\n References<\/strong> This article appeared in\u00a0Wise Traditions in Food, Farming and the Healing Arts<\/em>, the quarterly magazine of the Weston A. Price Foundation, Fall 2018<\/a>. Kendall\n Nelson, is a producer, director and activist who co-produced The \nGreater Good, an award-winning film that explores the controversy of \nvaccinations. She serves the Weston A. Price Foundation as a vaccine \nconsultant and activist, generating action alerts and articles on \nvaccine issues and legislation. She is a proud member of the \nInternational Women\u2019s Forum, which works to build better global \nleadership across careers, continents and cultures by connecting the \nworld\u2019s most preeminent women of significant and diverse achievement.<\/p>\n","protected":false},"excerpt":{"rendered":" October 27, 2018 By Kendall Nelson Ten years ago, my producing partners and I flew to Kansas to film with Gaby Swank, a beautiful fifteen-year-old girl who had suffered severe adverse reactions to the human papillomavirus (HPV) vaccine, Gardasil. Our intention was to interview Gaby so she could tell her vaccine-injury story in our documentary, […]<\/p>\n","protected":false},"author":1,"featured_media":3914,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[68],"tags":[],"class_list":["post-3911","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-vaccines"],"_links":{"self":[{"href":"https:\/\/novax.org\/index.php?rest_route=\/wp\/v2\/posts\/3911","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/novax.org\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/novax.org\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/novax.org\/index.php?rest_route=\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/novax.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=3911"}],"version-history":[{"count":4,"href":"https:\/\/novax.org\/index.php?rest_route=\/wp\/v2\/posts\/3911\/revisions"}],"predecessor-version":[{"id":6284,"href":"https:\/\/novax.org\/index.php?rest_route=\/wp\/v2\/posts\/3911\/revisions\/6284"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/novax.org\/index.php?rest_route=\/wp\/v2\/media\/3914"}],"wp:attachment":[{"href":"https:\/\/novax.org\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=3911"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/novax.org\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=3911"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/novax.org\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=3911"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
\nThe first two HPV vaccines to go to market were Merck\u2019s Gardasil vaccine\n in 2006 and GlaxoSmithKline\u2019s (GSK\u2019s) Cervarix in 2009. (Both are still\n marketed in other countries but are no longer in use in the U.S., \nhaving been replaced by Merck\u2019s Gardasil-9 vaccine in 2017.) HPV \nvaccines were problematic since their introduction, despite the \nstatement on the CDC\u2019s website that \u201cHPV vaccination gives your child \nsafe, effective, and long-lasting protection against HPV cancers.\u201d2<\/sup> Moreover, statistics show that Gaby is far from an anomaly: to date, over fifty-eight thousand<\/em> adverse reactions\u2014including four hundred twenty-seven deaths<\/em>\u2014have been reported after HPV vaccine injections in the U.S. alone.3<\/sup>\n What makes these numbers even more shocking is the U.S. Food and Drug \nAdministration\u2019s (FDA\u2019s) estimate that less than 1 percent of all \nvaccine-related adverse reactions are ever reported.4<\/sup><\/p>\n\n\n\n
\nWith statistics like these, one would think that the pharmaceutical \ncompanies that manufacture HPV vaccines and the authorities responsible \nfor protecting public health by ensuring vaccine safety and efficacy \nwould acknowledge that there is a problem, but instead of reevaluating \nHPV vaccines or pulling them off the market, these entities continually \ndismiss the onslaught of injuries as \u201ccoincidental\u201d or \u201cpsychosomatic.\u201d8<\/sup>\n HPV-vaccine-associated injuries include (but are not limited to) muscle\n pain and weakness; encephalopathy (brain inflammation); rheumatoid \narthritis; Guillain-Barr\u00e9 syndrome (GBS); multiple sclerosis; \namyotrophic lateral sclerosis (ALS); lupus; POTS; chronic fatigue \nsyndrome (CFS); primary ovarian failure (POV); strokes; seizures; facial\n paralysis; and sudden cardiac death.9<\/sup> Tragically, many adolescents have been accused of \u201cfaking\u201d their illnesses right up until their deaths.<\/p>\n\n\n\n
\nPerhaps the grossest example of FDA misconduct of all time is the fact that Gardasil was fast-tracked.13<\/sup>\n The time period from clinical trial to recommending the vaccine was \nonly four years, even though most vaccines take an average of three \nyears to develop and five to ten more for universal acceptance. \nFast-tracking is a process meant to \u201cfacilitate the development of drugs\n which treat a serious or life-threatening condition.\u201d14<\/sup> It \nis a misuse of fast-tracking to apply it toward the licensure of a \nvaccine designed to eliminate a sexually transmitted virus with which \nthe majority of sexually active men and women are infected at one point \nor another\u2014a virus that 90 percent of infected individuals clear \nnaturally from the body within two years.15<\/sup><\/p>\n\n\n\n
\nIf you think Merck can be trusted with your daughter\u2019s or son\u2019s \nwell-being, just look at its corporate history of engaging in criminal \nfraud with regard to other pharmaceutical products. For example, Merck \nmade a \u201chit list\u201d to \u201cdestroy,\u201d \u201cneutralize\u201d and \u201cdiscredit\u201d doctors who\n criticized the company\u2019s disastrous drug, Vioxx.18<\/sup> Ultimately, Merck entered a guilty plea and agreed to pay a fine of nine hundred fifty million dollars.19<\/sup>\n (This, of course, was not much of a fine considering that Gardasil \naccounted for more than two billion dollars in revenues in 2016 alone.20<\/sup>)\n Former Merck scientists have accused Merck in federal court of vaccine \nresearch fraud regarding the efficacy of its measles, mumps and rubella \n(MMR) vaccine.21<\/sup><\/p>\n\n\n\n
\nWhat are the cervical cancer facts? According to the CDC and the \nNational Institutes of Health (NIH), of the nearly 1.6 million diagnosed\n cancer cases (all cancers) and more than five hundred fifty thousand \ncancer deaths that occur in the U.S. annually, less than 3 percent \ninvolve chronic HPV-infection-associated cervical or other genital \ncancers in women and men.23<\/sup> For the period from 2003 through \n2007, the incidence rate for cervical cancer was 8.1 cases per hundred \nthousand women per year in the U.S. (versus upwards of forty per hundred\n thousand in high-incidence countries) and the mortality rate was 2.4 \ndeaths per hundred thousand women per year (compared to fifteen or more \nper hundred thousand in high-mortality countries).24<\/sup> While it\n may be true that some women who are chronically infected with HPV for \nmany years and who do not promptly identify and treat precancerous \ncervical lesions may go on to develop cervical cancer and possibly die, \nit is also important to know that after Pap test screening became a \nroutine part of health care for American women in the 1950s, cervical \ncancer cases in the U.S. dropped 74 percent\u2014and the CDC recommends \ncontinued Pap tests whether women get the HPV vaccine or not.25<\/sup><\/p>\n\n\n\n
\nSince 2017, Merck\u2019s Gardasil-9 has taken the place of both Gardasil and \nCervarix in the U.S. The CDC currently recommends Gardasil-9 for both \nfemales and males ages nine through twenty-six, administered using a \ntwo-dose or three-dose schedule and costing an average of two hundred \nten dollars per shot. Merck is marketing Gardasil-9 as an \u201cimprovement\u201d \nover Gardasil, claiming it will prevent 80 percent of all vulvar, \ncervical and anal cancers28 (up from the 65 percent for Gardasil). \nUnlike its predecessor, which targeted four strains of HPV, Gardasil-9 \ntargets nine of the more than one hundred fifty known strains of HPV, \nmost of which are harmless. Gardasil-9 also targets genital warts. \nHowever, the \u201cnew and improved\u201d version of Gardasil is no prize. What \nMerck does not advertise is the fact that Gardasil-9 contains more than \ndouble the toxic aluminum content of the original vaccine and has no \nfewer reported side effects.<\/p>\n\n\n\n
\nIn 2016, concurrent with the \u201cWho Knew<\/em>\u201d campaign, Merck \nsuffered a major blow as the American College of Pediatricians (ACPeds) \nsounded an alarm by releasing a statement expressing concerns about a \npotential connection between HPV vaccines and premature ovarian failure \n(POF) in adolescent girls.37<\/sup> Since the licensure of HPV \nvaccines, reports to VAERS include forty-eight cases of ovarian damage, \ntwo hundred fifty-six cases of spontaneous abortion, one hundred \nseventy-two cases of amenorrhea and one hundred seventy-two cases of \nirregular menstruation believed to be caused by HPV vaccination in the \nU.S.38<\/sup> That this is cause for concern is supported by a June 2018 study in the Journal of Toxicology and Environmental Health<\/em>\n that looked at a database of more than eight million American women and\n found a 25 percent increase in childlessness associated with HPV \nvaccination.39<\/sup> According to data from the CDC, more than 12 \npercent of American women\u2014one in eight\u2014have trouble conceiving and \nbearing a child.40<\/sup><\/p>\n\n\n\n
\nDespite all of the problems with HPV vaccines, U.S. politicians are \nincreasingly trying to mandate HPV vaccines for school admission. In \n2007, Governor Rick Perry of Texas signed an executive order that \nrequired HPV vaccination for all eleven- to twelve-year-old schoolgirls.\n Why? The CDC says it\u2019s important to vaccinate people before they become\n sexually active, but perhaps Perry\u2019s order had more to do with the fact\n that his former chief of staff was the leading lobbyist for Merck.43<\/sup>\n Fortunately, the Texas state legislature overturned Perry\u2019s order. Even\n so, Perry launched an unfortunate trend. Today, children in Rhode \nIsland, Virginia and the District of Columbia must be vaccinated against\n HPV to go to school (unless they take a religious or philosophical \nexemption), and in California, minors do not need parental consent to \nget HPV vaccines. In its statement communicating concern about primary \novarian failure, ACPeds expressed opposition to HPV vaccine mandates, \nsaying, \u201cThe College is opposed to any legislation which requires HPV \nvaccination for school attendance.\u201d37<\/sup><\/p>\n\n\n\n
\nI\u2019ve been in the vaccine awareness community for some time now. I\u2019ve \nmade a movie about the vaccine controversy; I\u2019ve worked hard to educate \npeople on the risks involved with vaccines; and I\u2019ve fought against \nseveral hundred bad pieces of vaccine legislation over the past three \nyears. In my experience, the HPV vaccine is the worst vaccine on the \nmarket. The truth is that HPV vaccines have injured and killed far more \nchildren than ever would have gone on to develop HPV-associated cancers \nwithout the vaccine.<\/p>\n\n\n\n
\n1. Grantham S, Ahern L, Connolly-Ahern C. Merck\u2019s One Less campaign: \nusing risk message frames to promote the use of Gardasil in HPV \nprevention. Communication Research Reports<\/em> 2011;28(4):318-326.
\n2. \u201cTalk to your child\u2019s doctor about HPV cancer prevention.\u201d https:\/\/www.cdc.gov\/hpv\/parents\/hpv-for-boys-and-girls\/index.html<\/a>.
\n3. \u201cSearch the U.S. Government\u2019s VAERS Data.\u201d http:\/\/www.medalerts.org\/<\/a>.
\n4. Lazarus R, Klompas M. Electronic support for public health\u2014Vaccine \nAdverse Event Reporting System (ESP: VAERS). Final report submitted to \nThe Agency for Healthcare Research and Quality (AHRQ). https:\/\/www.nvic.org\/CMSTemplates\/NVIC\/Pdf\/FDA\/ahrq-vaers-report-2011.pdf<\/a>.
\n5. Eckert LO, Anderson BL, Gonik B, Schulkin J. Reporting vaccine \ncomplications: what do obstetricians and gynecologists know about the \nVaccine Adverse Event Reporting System? Infect Dis Obstet Gynecol<\/em> 2013;2013:285257.
\n6. McNeil MM, Li R, Pickering S, Real TM, Smith PJ, Pemberton MR. Who is\n unlikely to report adverse events after vaccinations to the Vaccine \nAdverse Event Reporting System (VAERS)? Vaccine<\/em> 2013;31(24):2673-2679.
\n7. Liu XC, Bell CA, Simmonds KA, Svenson LW, Russell ML. Adverse events following HPV vaccination, Alberta 2006\u20132014. Vaccine<\/em> 2016;34(15):1800-1805.
\n8. Kinoshita T, Abe RT, Hineno A, Tsunekawa K, Nakane S, Ikeda S. \nPeripheral sympathetic nerve dysfunction in adolescent Japanese girls \nfollowing immunization with the human papillomavirus vaccine. Intern Med<\/em> 2014;53(19):2183-2200.
\n9. Tomljenovic L, Shaw CA. Human papillomavirus (HPV) vaccine policy and evidence-based medicine: are they at odds? Ann Med<\/em> 2013;45(2):182-193.
\n10. \u201cAllegations of scientific misconduct by GACVS\/WHO\/CDC representatives et al.\u201d http:\/\/sanevax.org\/wp-content\/uploads\/2016\/01\/Allegations-of-Scientific-Misconduct-by-GACVS.pdf<\/a>.
\n11. \u201cOfficials cover up dangers of HPV vaccines.\u201d http:\/\/www.greatergoodmovie.org\/newsviews\/officials-cover-up-dangers-of-hpv-vaccines\/<\/a>.
\n12. TNF-\u03b1 and cancer cachexia: molecular insights and clinical implications. Life Sci<\/em> 2017;170:56-63.
\n13. Tomljenovic L, Shaw CA. Too fast or not too fast: the FDA\u2019s approval\n of Merck\u2019s HPV vaccine Gardasil. J Law Med Ethics 2012;40(3):673-681.
\n14. \u201cFast track (FDA).\u201d https:\/\/en.wikipedia.org\/wiki\/Fast_track_(FDA)<\/a>.
\n15. Sudenga SL, Shrestha S. Key considerations and current perspectives \nof epidemiological studies on human papillomavirus persistence, the \nintermediate phenotype to cervical cancer. Int J Infect Dis<\/em> 2013;17(4):e216-e220.
\n16. \u201cHuman papillomavirus (HPV) disease and vaccine.\u201d https:\/\/www.nvic.org\/Vaccines-and-Diseases\/hpv.aspx<\/a>.
\n17. Martinez-Lavin M, Amezcua-Guerra L. Serious adverse events after HPV\n vaccination: a critical review of randomized trials and post-marketing \ncase series. Clin Rheumatol<\/em> 2017;36(10):2169-2178.
\n18. Edwards J. Merck created hit list to \u201cdestroy,\u201d \u201cneutralize\u201d or \u201cdiscredit\u201d dissenting doctors. Moneywatch<\/em>, May 6, 2009.
\n19. \u201cU.S. pharmaceutical company Merck Sharpe & Dohme to pay nearly \none billion dollars over promotion of Vioxx: Merck to pay $950 million \nfor illegal marketing.\u201d https:\/\/www.justice.gov\/opa\/pr\/us-pharmaceutical-company-merck-sharp-dohme-pay-nearly-one-billion-dollars-over-promotion<\/a>.
\n20. \u201cMerck announces fourth-quarter and full-year 2016 financial results.\u201d http:\/\/investors.merck.com\/news\/press-release-details\/2017\/Merck-Announces-Fourth-Quarter-and-Full-Year-2016-Financial-Results\/default.aspx<\/a>.
\n21. \u201cFormer Merck scientists sue Merck alleging MMR vaccine efficacy fraud.\u201d http:\/\/ahrp.org\/former-merck-scientists-sue-merck-alleging-mmr-vaccine-efficacyfraud\/<\/a>.
\n22. Huff EA. Dr. Russell Blaylock exposes criminal fraud of Gardasil, HPV vaccinations. Natural News<\/em>, Aug. 20, 2012.
\n23. Viens LJ, Henley SJ, Watson M et al. Human papillomavirus-associated cancers\u2014United States, 2008\u20132012. MMWR Morb Mortal Wkly Rep<\/em> 2016;65(26):661-666.
\n24. \u201cCervical cancer.\u201d https:\/\/report.nih.gov\/nihfactsheets\/viewfactsheet.aspx?csid=76<\/a>.
\n25. \u201cRationale for screening recommendations: impact of screening on cancer incidence and mortality.\u201d https:\/\/www.cdc.gov\/cancer\/knowledge\/provider-education\/cervical\/rationale.htm<\/a>.
\n26. Guo F, Hirth JM, Berenson AB. Comparison of HPV prevalence between \nHPV-vaccinated and non-vaccinated young adult women (20-26 years). Hum \nVaccin Immunother 2015;11(10):2337-2344.
\n27. http:\/\/ipaknowledge.org\/Maryland-HPV-Letter.php<\/a>.
\n28. \u201cGardasil-9 HPV vaccine might prevent 80 percent of cervical cancers.\u201d https:\/\/www.science20.com\/news_articles\/gardasil9_hpv_vaccine_might_prevent_80_percent_of_cervical_cancers-155469<\/a>.
\n29. Walker TY, Elam-Evans LD, Singleton JA et al. National, regional, \nstate, and selected local area vaccination coverage among adolescents \naged 13-17 years\u2014United States, 2016. MMWR Morb Mortal Wkly Rep<\/em> 2017;66(33):874-882.
\n30. McCabe C. Federal goal is to vaccinate 80% of boys and girls against HPV by 2020. The Wall Street Journal<\/em>, Nov. 10, 2014.
\n31. \u201cSide effects in young girls take Gardasil out from Japanese market.\u201d https:\/\/www.tokyotimes.com\/side-effects-in-young-girls-take-gardasil-out-from-japanese-market\/<\/a>.
\n32. \u201cSanofi sued in France over Gardasil vaccine.\u201d https:\/\/finance.yahoo.com\/news\/sanofi-sued-france-over-gardasil-vaccine-174058600\u2014finance.html.<\/a>
\n33. Chamberlain G. \u201cJudges demand answers after children die in controversial cancer vaccine trial in India.\u201d Daily Mail<\/em>, Jan. 13, 2015.
\n34. Yagi A, Ueda Y, Kimura T. A behavioral economics approach to the failed HPV vaccination program in Japan. Vaccine<\/em> 2017;35(50):6931-6933.
\n35. European Centre for Disease Prevention and Control (ECDC). \nIntroduction of HPV vaccines in European Union countries\u2014an update. \nStockholm: ECDC; 2012.
\n36. Gartland F. HPV vaccine support group concerned at side-effects. The Irish Times<\/em>, May 22, 2015.
\n37. \u201cNew concerns about the human papillomavirus vaccine.\u201d https:\/\/www.acpeds.org\/the-college-speaks\/position-statements\/health-issues\/new-concerns-about-the-human-papillomavirus-vaccine<\/a>.
\n38. McGovern C. Vaccine boom, population bust. Children\u2019s Medical Safety Research Institute, July 6, 2018. http:\/\/info.cmsri.org\/the-driven-researcher-blog\/vaccine-boom-population-bust<\/em>.
\n39. DeLong G. A lowered probability of pregnancy in females in the USA \naged 25-29 who received a human papillomavirus vaccine injection. J Toxicol Environ Health A<\/em> 2018;81(14):661-674.
\n40. \u201cInfertility.\u201d https:\/\/www.cdc.gov\/nchs\/fastats\/infertility.htm<\/a>.
\n41. Exposure to aluminum may impact on male fertility, research suggests. ScienceDaily<\/em>, Oct. 21, 2014.
\n42. Gajdov\u00e1 M, Jakubovsky J, V\u00e1lky J. Delayed effects of neonatal exposure to Tween 80 on female reproductive organs in rats. Food Chem Toxicol<\/em> 1993;31(3):183-190.
\n43. \u201cRick Perry\u2019s ties with Merck run deep.\u201d http:\/\/www.kbtx.com\/home\/headlines\/5546651.html<\/a>.
\n44. \u201cHPV vaccine.\u201d https:\/\/www.drugwatch.com\/vaccines\/hpv\/<\/a>.
\n45. \u201cFDA grants priority review to Merck\u2019s supplemental Biologics \nLicense Application (sBLA) for GARDASIL 9 in women and men ages 27 to 45\n for the prevention of certain HPV-related cancers and diseases.\u201d https:\/\/www.businesswire.com\/news\/home\/20180613005477\/en\/FDA-Grants-Priority-Review-Merck%E2%80%99s-Supplemental-Biologics<\/a>.
\n46. https:\/\/www.fda.gov\/downloads\/biologicsbloodvaccines\/vaccines\/approvedproducts\/ucm426457.pdf<\/a>.
\n47. \u201cMerck\u2019s former doctor predicts that Gardasil will become the greatest medical scandal of all time.\u201d http:\/\/healthimpactnews.com\/2014\/mercks-former-doctor-predicts-that-gardasil-will-become-the-greatest-medical-scandal-of-all-time\/<\/a>.<\/p>\n\n\n\n
original source:
\u0627\u0644\u0645\u0635\u062f\u0631 \u0627\u0644\u0623\u0635\u0644\u064a:
https:\/\/www.westonaprice.org\/health-topics\/the-troubling-truth-behind-hpv-vaccines-prepare-to-be-outraged<\/a><\/p>\n\n\n\nAbout Kendall Nelson<\/h4>\n\n\n\n